TrkB-Targeted Therapy for Mucoepidermoid Carcinoma

TrkB-Targeted Therapy for Mucoepidermoid Carcinoma

The brain-derived neurotrophic factor (BDNF)/tyrosine receptor kinase B (TrkB) pathway was previously associated with key oncogenic outcomes in a number of adenocarcinomas. The aim of our study was to determine the role of this pathway in mucoepidermoid carcinoma (MEC). Three MEC cell lines (UM-HMC-...

Full description

Bibliographic Details
Main Authors: Vivian P. Wagner, Manoela D. Martins, Esra Amoura, Virgilio G. Zanella, Rafael Roesler, Caroline B. de Farias, Colin D. Bingle, Pablo A. Vargas, Lynne Bingle
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Biomedicines
Subjects:
head and neck neoplasms
salivary gland neoplasms
adenocarcinoma
cell biology
therapeutics
Online Access:https://www.mdpi.com/2227-9059/8/12/531

Internet

https://www.mdpi.com/2227-9059/8/12/531

Similar Items